Citeline Podcasts

Norstella

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

  1. -1 J

    Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 21, 2026

    本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年4月17日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: Icotyde或将成为强生史上最重磅产品；daraxonrasib数据助力Revolution；Travere的Filspari成为首个用于治疗FSGS的药物；GSK重金押注B7-H4抗体药物偶联物；以及礼来夺得全球制药销售额榜首。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-KROBJCLAKVFBLCZ7BGBGCE3VDQ/

    18 min

  2. -1 J

    Scrip's Five Must-Know Things - Apr. 21, 2026

    Audio roundup of selected biopharma industry content from Scrip over the business week ended Apr. 17, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Icotyde could be J&J’s biggest ever product; daraxonrasib data boost Revolution; Travere’s Filspari becomes first drug for FSGS; GSK bets big on B7-H4 antibody-drug conjugate; and Lilly grabs top spot in global pharma sales. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-KROBJCLAKVFBLCZ7BGBGCE3VDQ/

    17 min

  3. -1 J

    The Generics Bulletin Podcast: Green Regulations With Medicines for Europe’s Adrian van den Hoven

    Generics Bulletin senior reporter Urtė Fultinavičiūtė speaks to Medicines for Europe’s director general Adrian van den Hoven about pertinent environmental regulation changes in the region.

    23 min

  4. -4 J

    Drug Fix: CBER Director Candidate Emerges, US FDA Promotes Leucovorin Pathway

    Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Senior Reporter Maaisha Osman and Editor-in-Chief Nielsen Hobbs discuss potential takeaways from the Trump Administration floating ophthalmologist, entrepreneur and Fox News contributor Houman David Hemmati as the next potential Center for Biologics Evaluation and Research director (:34), as well as the appointment of US Food and Drug Administration Principal Deputy Commissioner Sara Brenner to a position in the Health and Human Services Department (8:30). They also consider whether the FDA’s approach to adding an indication for leucovorin could be more widely used in the rare disease space (14:08) and new guidance for the agency’s plausible mechanism pathway (22:50).   #pharma #business   More On These Topics From The Pink Sheet   New CBER Director Candidate Could Signal Industry Cred Important Again: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/new-cber-director-candidate-could-signal-industry-cred-important-again-ZDJ4ECR4QNDBPBRTKNHD2B5R24/   US FDA’s Principal Deputy Commissioner Moving To HHS As Senior Counselor For Public Health: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-principal-deputy-commissioner-moving-to-hhs-as-senior-counselor-for-public-health-C64ZB6WRTNEJ7MC7I3ZY3KNP6I/   US FDA’s Literature-Based Leucovorin Approval May Offer A Rare Disease Template: https://insights.citeline.com/pink-sheet/rare-diseases/us-fdas-literature-based-leucovorin-approval-may-offer-a-rare-disease-template-Z34IYMFF35ENVJXV4N4ZT4GG6Q/   US FDA To Clarify Plausible Mechanism Framework With Genome Editing Guidances, Workshop: https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/us-fda-to-clarify-plausible-mechanism-framework-with-genome-editing-guidances-workshop-QTWKR3NCXJFJNKCOE3BTBSW4K4/

    28 min

  5. -5 J

    성숙기 진입 중인 ADC 시장…삼성바이오에피스, 차별화 전략 강화 (Korean-language podcast) Apr. 17, 2026

    김윤철 삼성바이오에피스 상무는  Scrip과의 인터뷰에서 ADC 및 기타 신약개발 전략 등에 대해 이야기했습니다. 이 기사를 요약한 내용입니다. (AI 기반 텍스트 음성 변환 및 음성 모방 도구의 도움을 받아 제작되었습니다) Story link: https://insights.citeline.com/scrip/focus-on-asia/south-korea/samsung-bioepis-sharpens-differentiation-strategy-as-global-adc-market-matures-T4E7D2U4DZFJFIERGRWM7PECTM/

    4 min

  6. -5 J

    Japan Q1 Roundup: Key Commercial and Policy/Regulatory Developments

    Join Scrip and The Pink Sheet's Tokyo-based team Lisa Takagi and Ian Haydock for a roundup of key commercial and policy/regulatory developments in Japan's biopharma market over the first few months of this year, including some important corporate divestments and new product approvals. Also a look at how the Iran war is impacting the healthcare sector in the country.

    10 min

  7. 13 AVR.

    Lilly TuneLab: Breaking Data Silos in Biotech with Federated Learning

    How can small biotechs tap billion‑dollar AI models without giving up their data? David Wild talks with Eli Lilly's Aliza Apple about Lilly TuneLab, a federated learning platform that lets companies use Lilly’s in-house drug discovery models while keeping their IP and datasets fully private. They dive into early use cases in ADMET and antibody developability, what early-stage users actually do in their first 90 days, and how shared models could reshape the economics of drug R&D.

    28 min

  8. 13 AVR.

    Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 10, 2026

    本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年4月10日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 特朗普政府对部分药品及原料药征收100%关税；美国关税政策给获美批准的中国药品带来阴影； 吉利德收购Tubulis；深入解析Neurocrine对Soleno的收购要约；以及对第一季度并购活动的分析。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-O7KEIWGMHBCLZBHKJPKGHOZYPE/

    18 min
Tout afficher (547)

À propos

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Informations

  • Création
    Norstella
  • Années d’activité
    2014 - 2026
  • Épisodes
    547
  • Classification
    Tous publics
  • Copyright
    © 24c12740-34d6-11f1-9889-f71e988e8a77
  • Site web de l’émission
    Citeline Podcasts

Vous aimeriez peut‑être aussi